Evidence map›Paper›PMID 14989409›Full record

ArticleSchizophrenia bulletin2003

The assessment of "prodromal schizophrenia": unresolved issues and future directions.

Todd Lencz, Christopher W Smith, Andrea M Auther, Christoph U Correll, Barbara A Cornblatt

Abstract read
PubMed Publisher
In one paragraph

Article in Schizophrenia bulletin, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Glycine treatment of the risk syndrome for psychosis: report of two pilot studies.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2013
    Trial
  3. Subjective cognitive complaint in at-risk mental states.Schizophrenia research. Cognition · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Prediction and prevention of schizophrenia: what has been achieved and where to go next?World psychiatry : official journal of the World Psychiatric Association (WPA) · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Research in people with psychosis risk syndrome: a review of the current evidence and future directions.Journal of child psychology and psychiatry, and allied disciplines · 2010
    Review
  18. Pediatric bipolar disorder: evidence for prodromal states and early markers.Journal of child psychology and psychiatry, and allied disciplines · 2010
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Todd LenczAlbert Einstein College of Medicine, Bronx, NY, USA. lencz@lij.edu
Christopher W Smith
Andrea M Auther
Christoph U Correll
Barbara A Cornblatt

Funding

COURSE OF ILLNESS IN SCHIZOPHRENIA: OPTIMIZING OUTCOMESP30MH060575 · NIMH · LONG ISLAND JEWISH MEDICAL CENTER · PI KANE, JOHN M · 2000 to 2004
$6.5M
CHARACTERIZATION OF PRODROMAL SCHIZOPHRENIAR01MH061523 · NIMH · LONG ISLAND JEWISH MEDICAL CENTER · PI CORNBLATT, BARBARA A. · 2000 to 2009
$3.6M
Identifying &Characterizing Prodromal SchizophreniaK01MH065580 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI LENCZ, TODD · 2003 to 2007
$675k
BIOBEHAVIORAL INDICATORS OF SCHIZOPHRENIAR01MH050203 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · PI CORNBLATT, BARBARA A. · 1995 to 1998
–
NIMH NIH HHS MH-50203NIMH NIH HHS MH-60575NIMH NIH HHS MH-61523NIMH NIH HHS MH-65580
6 · The paper itself

Abstract

Because of the novelty of research with clinical high risk ("prodromal") patients, many unresolved issues exist concerning how the prodromal state is defined and measured. Data are presented from the Recognition and Prevention (RAP) program at the Zucker Hillside Hospital to address several outstanding questions. Baseline attenuated positive symptoms were rated in 42 putatively prodromal patients in the RAP program using the Scale of Prodromal Symptoms (SOPS). Followup data of 6 months or more were available on 34 of these subjects; 9 of these (26.5%) developed psychotic disorders. Patients who developed psychosis had significantly higher SOPS positive symptom scores at baseline than those who did not. Various thresholds, using both total SOPS positive symptom scores and highest single item score, significantly predicted transition to psychosis, which calls into question appropriate cutoffs for the distinction between health, prodromal status, and psychosis. The SOPS positive symptom "conceptual disorganization" was found to be significantly related to disorganized behavior but not to other positive symptoms or to psychotic outcome, suggesting the importance of examining dimensions of psychopathology. The dimensional quantification of prodromal symptom severity may be an important direction for future studies of the assessment of at-risk states.

Indexed as

AdolescentAdultChildDiagnosis, DifferentialDisease ProgressionFemaleFollow-Up StudiesHumansMalePsychiatric Status Rating ScalesPsychometricsReference ValuesReproducibility of ResultsResearchSchizophrenia, DisorganizedSchizotypal Personality Disorder

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.